Archive

Archive(1)

Hot Papers(1,022)

Ago/siRNA/saRNA(153)
Alternative splicing(92)
Anti-miR/antagomir(118)
antisense(10)
Antisense/RNase H(186)
Aptamer(141)
ASO(1)
circRNA(23)
Clinical Development(68)
Covid-19(1)
Delivery(124)
Gene editing(87)
Immune Stimulation(30)
immunostimulation(7)
Immunostimulation(4)
Long noncoding RNA(95)
Medicinal Chemistry(67)
MicroRNA(178)
mRNA(58)
Other papers of interest(137)
Pre-Clinical Research(47)
Reviews(100)
Ribozyme(30)
siRNA(16)
Splice modulation(43)
Toxicology(31)

Paper of the Month(33)

The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

October 11–14, 2026 | Denver, CO

Stay Updated!

OTS Webinars

Events Calendar

Annual Meetings

The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

October 11–14, 2026 | Denver, CO

Stay Updated!

OTS Webinars

Events Calendar

Annual Meetings

Category

QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study

Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides

A mouse tissue atlas of small noncoding RNA.

Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function

2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA

Category

QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study

Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides

A mouse tissue atlas of small noncoding RNA.

Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function

2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA

Subscribe to our Newsletter

Resources

Stay Connected

Search

The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

October 11–14, 2026 | Denver, CO

Stay Updated!

OTS Webinars

Events Calendar

Annual Meetings

The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

October 11–14, 2026 | Denver, CO

Stay Updated!

OTS Webinars

Events Calendar

Annual Meetings

Category

Category

Subscribe to our Newsletter

Resources

Stay Connected

Search

Login to your account

Reset Password

Signup to your Account

Answers

Job Alerts

Account Activation